Inside the unconventional FDA panel that could reshape the peptide industry

Inside the unconventional FDA panel that could reshape the peptide industry

Olena Malik/Getty Images

Nearly 2 years after Robert F. Kennedy Jr. vowed to end the FDA's "war" on peptides, he has convened an unusual FDA advisory committee.

No comments

Read more